Find Academic Supervisors

Dr. Jamie O'Sullivan is a Lecturer and Principal Investigator at the Irish Centre for Vascular Biology, School of Pharmacy and Biomolecular Sciences, Royal College of Surgeons in Ireland (RCSI). Her research focuses on the bidirectional interactions between coagulation pathways and cancer metastasis, particularly involving von Willebrand Factor (VWF) in diseases like cancer, malaria, and inflammatory conditions. She holds a BSc in Biomedical Science from University College Cork and a PhD in Haematology from Trinity College Dublin, supported by an Irish Research Council scholarship. Notable awards include the 2018 Martin Villar Haemostasis Award and a Novartis Fellowship. Education: PhD in Haematology, Trinity College Dublin (2015) BSc Biomedical Science, University College Cork (Ireland) BSc Biomedical Science, Cork Institute of Technology (Ireland) Research Interests: Her work explores VWF's roles in cancer metastasis, thrombosis, and vascular biology. Key areas include VWF clearance pathways, endothelial-tumor interactions, and therapeutic targeting of VWF in diseases like multiple myeloma and breast cancer. Grants & Funding: Her lab is supported by grants from Science Foundation Ireland, the Irish Research Council, and industry collaborations. Ongoing projects include studies on the VWF-ADAMTS13 axis in cancer-associated thrombosis and the role of tinzaparin in breast cancer metastasis. Awards: 2018 Martin Villar Haemostasis Award Novartis Fellowship (2017–2019) Labs & Teams: The O'Sullivan Lab is part of the Irish Centre for Vascular Biology, collaborating with international groups like KU Leuven University. She also leads the StAR Programme in RCSI, training future researchers in vascular biology.

• Vascular Biology
• Hematology
• Cancer Biology
• +5 more

Prof Annie Curtis is an Associate Professor at the School of Pharmacy and Biomolecular Sciences, Royal College of Surgeons in Ireland (RCSI). She leads the Curtis Clock Lab, focusing on circadian rhythms' impact on immunity and inflammation. Her research bridges chronobiology with immunology, investigating how molecular clocks regulate innate immune function, particularly in macrophages and dendritic cells. Education: B.A. in Genetics, Trinity College Dublin (1998) PhD in Cardiovascular Pharmacology, University of Pennsylvania (2005) Postgraduate Diploma in Health Professions Education, RCSI (2018) Research Interests: Circadian control of immunity, inflammation, and metabolism. Key areas include: Chronopharmacology for inflammatory disease treatment timing Clock regulation of macrophage and dendritic cell function Interplay between circadian rhythms and metabolic reprogramming in immunity Grants & Funding: EU Horizon 2020/2023: METABOLATE project SFI Career Development Award (2017) SFI Frontiers Award (2021) ChronoVac: Circadian clock-enhanced vaccine efficacy (2021-2025) Awards: L'Oréal-UNESCO Women in Science Fellowship (2017) Roche Medal - Trinity Biomedical Science Institute (2012) ATVB Junior Investigator Award (2006) Lab & Collaborations: Principal Investigator in RCSI's Tissue Engineering Research Group (TERG), and funded investigator in AMBER and FutureNeuro2 centres. Active in science communication through media appearances.

• Immunology
• Chronobiology
• Inflammation
• +4 more

Professor Niamh Moran is a leading academic at the Royal College of Surgeons in Ireland (RCSI), serving as a Professor in the School of Pharmacy and Biomolecular Sciences and a member of the Molecular & Cellular Therapeutics department. Her academic roles have included Academic Director of the HEA Postgraduate Training Programme (2001–2007) and Head of the School of Postgraduate Studies (2013–2017). She holds a BSc (1983) and PhD (1987) from University College Dublin. Her research focuses on thrombosis, platelet biology, and vascular diseases, with contributions to integrin activation mechanisms, bioactive peptide delivery systems, and platelet secretome analysis. Key areas include understanding arterial thrombosis, platelet modulation in clinical scenarios like stroke and pregnancy, and cancer-cell-induced platelet activation. Her work aligns with the UN Sustainable Development Goal 3 (Good Health and Well-Being). Recent studies explore platelet activation in COVID-19, vaccine-induced thrombocytopenia, and the role of platelets in cancer metastasis. Over 97 publications and numerous grants highlight her impact, including funded projects on platelet function in cardiovascular systems and collaborations across disciplines. Professor Moran has supervised multiple PhD theses, including projects on vitamin D’s role in platelet function and cancer-cell-induced platelet secretion. She has pioneered educational initiatives, such as a unique PhD program in Biomedical Sciences and a Science Art initiative. Her lab and teams are integral to RCSI’s research ecosystem.

• Thrombosis
• Platelet Biology
• Vascular Diseases
• +3 more

Stephen Madden is Senior Lecturer in Computational Biology at RCSI's Data Science Centre, holding a PhD from University College Dublin. His research applies bioinformatics and statistical approaches to cancer genomics and precision medicine. Key research areas include multi-omics integration in breast cancer, therapeutic target discovery, and predictive modeling of treatment response. Recent work examines extracellular vesicles in neonatal development, immunothrombosis mechanisms in hematologic malignancies, and implantable sensor technologies. Publications demonstrate expertise in proteomic profiling, preclinical model development, and computational method implementation. Teaching focuses on programming, transcriptomics, and genomics for biomedical students. He serves as Deputy Director for the MSc in Technologies and Analytics in Precision Medicine and supervises PhD projects in cancer systems biology.

• Cancer Genomics
• Transcriptomics
• Next-Generation Sequencing
• +4 more

Seamus Hussey is a Clinical Senior Lecturer at the Royal College of Surgeons in Ireland (RCSI), Department of Paediatrics and Child Health. He is also a Consultant Paediatric Gastroenterologist at Our Lady’s Children’s Hospital, Crumlin, Dublin. His primary research focus is on paediatric inflammatory bowel disease (IBD), particularly the microbiome in IBD, clinical outcomes, and novel therapeutic strategies. He leads the DOCHAS project (Determinants and Outcomes in Children and Adolescents with IBD) at the National Children’s Research Centre. Prof. Hussey is an elected member of the Porto IBD Group of the European Society for Paediatric Gastroenterology, Hepatology, and Nutrition (ESPGHAN). His research interests include paediatric IBD epidemiology, host-microbial interactions, and translational therapies. He collaborates internationally on projects related to IBD pathogenesis and treatment efficacy. His recent publications highlight advancements in understanding IBD mechanisms, including neutrophil subsets’ role in intestinal disease and the impact of anti-TNF therapy in obese children with IBD. Prof. Hussey has secured grants for projects such as 'Engineered recombinant activated protein C as a novel therapeutic agent for children with IBD' and 'Outcomes of Modified Exclusive Elemental Nutrition in Paediatric Crohn’s Disease.' He is actively involved in clinical training, supervising Specialist Paediatric Registrar Trainees since 2015. Professional roles include Clinical Lead in Paediatric Gastroenterology and membership in the National Endoscopy Clinical Advisory Group. His work aligns with UN Sustainable Development Goal 3 (Good Health and Well-Being), focusing on improving paediatric gastrointestinal health outcomes globally.

• Paediatric Inflammatory Bowel Disease
• Microbiome in IBD
• Clinical Outcomes Research
• +4 more

Dr. Ann Hopkins is an Associate Professor in the Department of Surgery at RCSI University of Medicine and Health Sciences, Dublin, Ireland. Her roles include directing the RCSI International Electives Programme and serving as Education Lead for the Beaumont RCSI Cancer Centre. She holds positions spanning from College Lecturer (2005–2007) to Senior Lecturer (2016–2023) at RCSI, with prior postdoctoral experience at Emory University and University College Dublin. Her education includes a PhD in Pharmacology (UCC, 1999), B.Sc. with honours (UCC, 1995), and a Higher Diploma in Health Professions Education (RCSI, 2018). She is fluent in German and French. Research focuses on translational cancer biology, particularly the role of Junctional Adhesion Molecule-A (JAM-A) in breast cancer and multiple myeloma. Her work explores JAM-A’s contribution to aggressive cancer phenotypes, druggability, and immune system interactions using non-animal models. Key areas include drug resistance, metastasis, and precision medicine. Her publications (129+ articles) span oncology, cell biology, and immunology, emphasizing JAM-A’s therapeutic potential. Grants include projects on xenograft models (Health Research Board, 2022–2025), JAM-A/HER2 signaling (EU Horizon Europe, 2024–2026), and educational outreach. Awards and recognitions are not explicitly stated, but her contributions to collaborative research and patient education (e.g., 'A Day in the Life of a Cancer Researcher' workshop) highlight her impact. She has supervised numerous graduate students, including Emily R, Saraswati S, and Frances D, focusing on JAM-A’s role in cancer progression and therapeutic development.

• Translational Cancer Biology
• Breast Cancer
• Drug Resistance
• +3 more

Sharon Duffy is a Lecturer in Medical Science at the Department of Biopharmaceutical & Medical Science and serves as a Principal Investigator at the Medical and Engineering Technologies Gateway (MET) in Galway City, Ireland. Her work integrates computational modeling and experimental studies to address challenges in thrombosis, hematology, and biomedical engineering. Her research interests span thrombus dynamics, clot mechanics, and fibrinolysis under flow conditions. She develops numerical models to study thrombectomy devices and thrombus maturation, with applications in stroke and vascular interventions. No scientific awards mentioned. No advising students or grants listed. She is affiliated with the Medical and Engineering Technologies Gateway (MET), focusing on interdisciplinary medical-engineering research.

• Medical Science
• Biomedical Engineering
• Hematology
• +3 more

Patrick Broderick is a Lecturer in the Department of Social Sciences at Atlantic Technological University. His research focuses on evidence-based rehabilitation techniques for stroke patients and communication disorders. Broderick employs systematic reviews and meta-analyses to evaluate therapeutic interventions. His work examines: Motor function recovery through cross-education Complementary therapies like Pilates Sensory substitution for gait rehabilitation Minimally invasive treatments for vascular conditions His publications demonstrate consistent application of rigorous statistical methods to assess clinical outcomes. Research trends show strong emphasis on cost-effective interventions and quality-of-life metrics. He collaborates with multidisciplinary teams across healthcare fields but no specific labs or grants are detailed in available sources.

• Stroke Rehabilitation
• Systematic Reviews
• Meta-Analysis
• +2 more

James O'Donnell is a Professor of Vascular Biology and Director of the Irish Centre for Vascular Biology at the Royal College of Surgeons in Ireland (RCSI). He holds clinical appointments as a Consultant Haematologist at St. James's Hospital, Dublin. His academic career includes a PhD from Imperial College London (2001) and clinical training at leading institutions in Australia and the UK. He is a Fellow of the Royal College of Physicians of Ireland and the Royal College of Pathologists (UK). Education: MB, BCh, BAO, BA - Trinity College Dublin PhD - Imperial College London His research focuses on vascular biology, thrombosis, and haemostasis, with emphasis on von Willebrand factor, bleeding disorders, and cardiovascular disease mechanisms. His lab has secured over £12 million in grants from funders like Science Foundation Ireland, the Health Research Board, and the Wellcome Trust. Key achievements include pioneering studies on von Willebrand disease pathogenesis and translational research in haemophilia therapy. Awards & Recognition: Pioneer recipient of Science Foundation Ireland's President of Ireland Young Investigator Award Grants & Collaborations: Lead over 30 funded projects since 2006, including EU Horizon Europe initiatives and industry partnerships Directed the Irish Centre for Vascular Biology, fostering interdisciplinary research in vascular medicine His work has produced >130 peer-reviewed publications in top journals like the New England Journal of Medicine and Blood, and he regularly presents at major hematology conferences such as the American Society of Hematology Annual Meeting.

• Vascular Biology
• Thrombosis
• Haemostasis
• +6 more

Prof. Dermot Cox is an Associate Professor at Royal College of Surgeons in Ireland (RCSI), leading pharmacology efforts in the School of Pharmacy and Biomolecular Sciences. His career spans academic roles since 1997, including Senior Lecturer (2006-2017) and Lecturer positions across RCSI's Medical School and Pharmacy departments. He holds a BSc in Pharmacology (University College Dublin, 1983) and a PhD in Immunology (Dublin City University, 1989). His research focuses on Platelet Biology , Vascular Diseases , and Thrombosis/Haemostasis , with contributions to drug discovery and clinical pharmacology. He has advised pharmaceutical companies on pre-clinical and clinical trials, and taught drug development modules for a Masters in Pharmaceutical Medicine. Professional roles include Academic Editor for PLOS One, advisory board member for the Journal of Thrombosis and Haemostasis, and president of the International Society on Thrombosis and Haemostasis SSC meeting (2018). He also completed a PG Dip in Medical Education at RCSI (2014-2015). Non-academic experience includes a 6-year tenure as Section Chief of GPIIb/IIIa antagonist drug research at Fujisawa Pharmaceutical (Japan) and postdoctoral work at the Royal Hallamshire Hospital (UK).

• Platelet Biology
• Vascular Diseases
• Immunology
• +5 more

Dr. Aamir Hameed is Senior Lecturer in Anatomy and Regenerative Medicine at RCSI and Principal Investigator with the Tissue Engineering Research Group. He obtained his MD through cardiovascular regeneration research at RCSI and MBBS from University of Karachi. Hameed completed surgical residencies at Aga Khan University Hospital and research training at MIT and Houston Methodist. His research develops minimally invasive solutions for cardiovascular diseases. Current focus includes Pumpinheart Ltd. (co-founded 2022), developing an implantable pump for heart failure with preserved ejection fraction (HFpEF). The technology was selected for MedTech Innovator 2023 cohort and received EI commercialization support. Additional projects include SmartPleuro for malignant effusions (HSE €150K) and targeted drug delivery systems. Hameed coordinates anatomy education for Graduate Entry Medicine and Paramedic programs. He serves as Review Editor for Frontiers in Medical Technology and contributes to European Society of Cardiology Working Groups on Cardiovascular Surgery and Regenerative Medicine.

• Cardiovascular Tissue Engineering
• Minimally Invasive Devices
• Heart Failure Devices
• +1 more

Dr. Patrick Walsh is an Associate Professor in Eighteenth-Century Irish History at Trinity College Dublin's Department of History. His research focuses on Ireland's colonial and imperial history, with a comparative perspective emphasizing economic history. He co-directs the Trinity Colonial Legacies project, a public history initiative collaborating with institutions like the Office of Public Works and the Royal Dublin Society. Dr. Walsh teaches undergraduate and postgraduate modules on Irish, Atlantic, economic, and financial history, including the history of capitalism. His current projects include a monograph on state formation in eighteenth-century Ireland and an exploration of financial legacies of Irish property ownership. He actively engages with policymakers and heritage professionals to bridge academic and public history.

• Eighteenth-Century History
• Irish History
• Colonial History
• +4 more

Edel Burton is a Pharmacist and HRB SPHeRE PhD Scholar at the School of Public Health , University College Cork (UCC). Her research focuses on chronic disease prevention, antimicrobial stewardship, and pharmacotherapy optimization in aging populations, with a particular emphasis on the impact of the COVID-19 pandemic on prehospital emergency care for stroke and transient ischaemic attacks (TIAs). She holds First Class Honours degrees in Pharmacy (BPharm, 2019) and Master of Pharmacy (2020), supported by the UCC Quercus Taught Masters Academic Scholarship. Her Master’s thesis explored antimicrobial processes in Irish hospitals. Education & Awards: Bachelor of Pharmacy (First Class Honours), UCC, 2019 Master of Pharmacy (First Class Honours), UCC, 2020 UCC Quercus Taught Masters Academic Scholarship Research Experience: Edel has clinical experience in community and hospital settings, including work on the Horizon 2020-funded OPERAM clinical trial. She currently collaborates with the ESPRIT research team to address health-services challenges in chronic disease prevention and emergency care. Her PhD project examines pandemic-related disruptions to stroke/TIA emergency care pathways. Research Themes: Her work bridges clinical practice and policy, addressing antimicrobial stewardship, geriatric pharmacotherapy, and pandemic resilience in healthcare systems. She employs mixed-methods approaches to analyze prescribing patterns, healthcare disparities, and system-level interventions. Grants & Collaborations: Funded by the HRB SPHeRE Programme, her research aligns with national priorities in chronic disease management and public health preparedness. She contributes to interdisciplinary networks like IPERN to advance paramedicine education and emergency care research. Labs/Teams: Member of the ESPRIT research team at UCC’s School of Public Health.

• Chronic Disease Prevention
• Antimicrobial Stewardship
• Pharmacotherapy Optimization
• +3 more

Prof. Martin Hegner is a Professor of Physics at Trinity College Dublin (TCD) and leads the Nanobio-Nanomechanics Group at the Centre for Research on Adaptive Nanostructures and Nanodevices (CRANN). He holds a PhD in Experimental Physics from ETH Zurich and has held academic positions at the University of Basel and UC Berkeley. His research focuses on bioanalytics at molecular and systems levels, including single-molecule manipulation with optical tweezers, nanomechanical diagnostics, and MEMS-based sensor development. Key areas include nucleic acid screening, thrombosis diagnostics, and translational medical applications. Education: Studied Life Sciences at ETH Zurich (BSc 1984), earned a Diploma (MSc equivalent) in Cellular Biochemistry (1989) and a PhD in Protein Translocation (1994). Postdoctoral work included pioneering single-molecule techniques at UC Berkeley under Prof. Carlos Bustamante. Research Themes: Single molecule mechanics and biosensing Nanomechanical diagnostic platforms for clinical use Protein translocation and ribosomal dynamics MiRNA/siRNA pharmacokinetics Collaborations with hospitals (St. James, Lund) and institutes (Swiss Tropical Institute) Labs & Teams: Directs the Nanobio-Nanomechanics Group with ~2 researchers, emphasizing interdisciplinary innovation in nanobiotechnology. Current projects include next-gen in vitro diagnostics and label-free immunoassays for malaria and SARS-CoV-2 variants. Teaching & Mentorship: Contributes to TCD's physics curriculum and supervises postgraduate research in biophysics, nanotechnology, and analytical instrumentation.

• Nanobiotechnology
• Biophysics
• Nanomechanics
• +5 more

Dr. Tao Zhang serves as a Lecturer at Technological University Dublin's School of Food Science and Environmental Health, where he chairs the nationally award-winning Higher Certificate in Science in Pharmacy Technician Studies (TU654|TU657). He holds key roles including membership in TU Dublin's Academic Regulations Oversight Committee, Faculty Board (Sciences & Health), and affiliations with the Royal Society of Chemistry, Society for Medicinal Plant Research, and International Natural Product Sciences Taskforce. His educational background includes: BSc (Hons) in Pharmaceutical Technology (First Class Honours) from Dublin Institute of Technology, 2004 Postgraduate Diploma in Quality Improvement from Trinity College Dublin, 2006 PhD in Pharmacy Research from Trinity College Dublin's School of Pharmacy and Pharmaceutical Sciences, 2009 Dr. Zhang's research bridges educational innovation and scientific discovery . In education, he pioneers curriculum design integrating professional development training to cultivate graduate attributes, evidenced by the 2023 National AHECS Employability Award for his Pharmacy Technician Programme. Scientifically, he develops novel indane hybrid skeletons targeting CNS disorders, inflammation, and cancer, while advancing ethnopharmacology through isolation of bioactive molecules from natural resources like Irish bogland plants and traditional medicines including Lycium barbarum . His 2023-2025 publications reveal three dominant themes: vitamin K2 therapeutics (spanning deficiency implications and clinical perspectives), indane-based drug scaffolds for prostate cancer and inflammation, and educational transformation in pharmacy technician training—often intersecting through interdisciplinary collaborations like the €6M 'Unlocking Nature's Pharmacy' project with Trinity's NatPro centre. Key recognitions include: National AHECS Employability Award for Research Informed Practice (2023) Wellcome Trust Advanced Training Bursary Enterprise Ireland Research Innovation Voucher Wellcome Trust Strategic Translation Award TU Dublin First-Time Supervisor Award As Programme Chair, Dr. Zhang mentors pharmacy technician students while securing substantial research funding including the €6M IIP project 'Unlocking Nature's Pharmacy from Bogland Species' and Wellcome Trust awards. His grants support both natural product research and educational innovations like sustainable ePortfolio models for professional development. He operates as Principal Investigator at Trinity's NatPro Centre for Natural Products Research and Associate Research Fellow at Trinity's School of Pharmacy, leveraging industry experience from Trino Therapeutics (where he advanced PH46A to clinical trials) and APC Ltd to lead interdisciplinary teams in (bio)pharmaceutical process development and natural product analysis.

• Pharmaceutical Sciences
• Medicinal Chemistry
• Natural Products Research
• +3 more